The real reason it has taken so long to return to the Moon

Artemis programme progress: after a decades-long gap caused by post-Apollo budget cuts and shifting priorities, NASA retained Orion and SLS technologies from the cancelled Constellation programme and completed the uncrewed Artemis I mission. Artemis II is being prepared as the first crewed lunar flyby, setting up a human landing planned for Artemis IV; the article highlights that sustained political will and funding across multiple administrations has been the primary constraint.

Analysis

The most investable structural outcome is program “stickiness”: multi-decade hardware carryover and follow-on sustainment creates long-duration, cost-plus cash flows for large primes that win systems integration work. That favors a small set of incumbents with in-house propulsion, avionics and integration capabilities and creates concentrated single-source supplier risk (a single engine or avionics failure cascades across schedules and revenues). Over the next 12–36 months this manifests as stable revenue visibility but capped upside—contracts protect margins against schedule slips, so equity upside requires either program scope expansion or margin re-leverage via commercial spin-ins.

A key second-order dynamic is commercial disruption risk. If low-cost heavy lift (Starship-like economics) proves operational at scale within 2–4 years, launch price per tonne could compress >50%, rerouting non-NASA lunar logistics to commercial providers and stripping future NASA-funded cadence from legacy SLS-centric suppliers. That’s asymmetric: a successful commercial entrant would materialize rapidly and cut tail revenues for incumbents, while continued NASA primacy preserves multi-year revenue for primes.

Supply-chain constraints (specialty alloys, cryogenic turbopumps, high-reliability avionics) create near-term pricing power for firms that own manufacturing capacity; expect supplier margins to outpace primes for 6–24 months if capacity tightness persists. Political/capitol risk is front-loaded: annual appropriations cycles and the 2024–2025 election window are the most likely venues for program re-scoping; a negative appropriations surprise could reduce FY+1 toplines by double digits for exposed suppliers within 3–6 months. A successful crewed test or high-visibility failure are binary catalysts that could move segment multiples by 15–40% within days/weeks of the event.

Key Decisions for Investors

• Overweight LMT (Lockheed Martin) — 12–18 month horizon. Position size 2–3% NAV. Rationale: highest probability to capture integration/sustainment awards; target +12–18% if FY25 budgets remain flat-to-up. Downside: -8–12% on >5% program cuts or major program failure; use a 10% trailing stop.
• Overweight NOC (Northrop Grumman) — 9–18 month horizon. Position size 1.5–2.5% NAV. Rationale: exposure to mission systems and spacecraft subsystems gives near-term revenue visibility. Risk/reward: expect 10–15% upside if schedules hold; downside 10%+ on negative appropriation headlines.
• Relative trade — long RTX (Raytheon Technologies) / short BA (Boeing) pair — 6–12 months. Idea: RTX benefits from defense/NASA subcontract durability while BA carries concentrated program and production scrutiny. Target relative outperformance of 8–15%; cut the pair if BA outperforms RTX by 5% in 30 trading days (risk control).
• Tactical options play on MAXR (Maxar) — buy 9–12 month call spread (buy calls / sell higher strike). Position size small (<1% NAV). Rationale: satellite/remote sensing wins and lunar-mapping related revenues are binary catalysts; limited premium downside with 3x+ payoff if contracts accelerate.
• Hedge / event protection — buy put protection on a basket of small-cap aerospace suppliers (or use an ETF overlay) covering the next 6–12 months. Rationale: protects against an abrupt pivot of NASA funding or a major mission failure which would disproportionately hit single-program suppliers; cost to hold should be budgeted as insurance (25–50bps annualized).